Drug profile · INN
somatropin
GENOTROPIN GOQUICK
somatropin (GENOTROPIN GOQUICK) is a growth hormone receptor agonist. Associated with Pfizer Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — somatropin
- US status
- approved
- Class
- Systemic hormonal preparations (H01)
- Route
- INJECTION
- Patents
- 2
- Programs
- 16
- Data quality
- 0.84
Quick answer
somatropin (GENOTROPIN GOQUICK) is a growth hormone receptor agonist. Associated with Pfizer Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Growth hormone receptor agonist
Primary target: Growth hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is somatropin?
somatropin (GENOTROPIN GOQUICK) is a growth hormone receptor agonist. Associated with Pfizer Australia Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for somatropin?
GENOTROPIN GOQUICK is a marketed brand name for somatropin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of somatropin?
somatropin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.